PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30676743-2	2019	This study investigated the interaction of recombinant CYP3A4 with a nonspecific inhibitor metyrapone, antifungal drug fluconazole, and protease inhibitor phenylmethanesulfonyl fluoride (PMSF).	Metyrapone	91-101	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	55-61	
30676743-3	2019	Metyrapone and fluconazole are classic type II ligands that inhibit CYP3A4 with medium strength by ligating to the heme iron, whereas PMSF, lacking the heme-ligating moiety, acts as a weak type I ligand and inhibitor of CYP3A4.	Metyrapone	0-10	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	68-74	
30676743-3	2019	Metyrapone and fluconazole are classic type II ligands that inhibit CYP3A4 with medium strength by ligating to the heme iron, whereas PMSF, lacking the heme-ligating moiety, acts as a weak type I ligand and inhibitor of CYP3A4.	Metyrapone	0-10	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	220-226